ZA200908089B - Induction of tolerogenic phenotype in mature dendritic cells - Google Patents

Induction of tolerogenic phenotype in mature dendritic cells

Info

Publication number
ZA200908089B
ZA200908089B ZA200908089A ZA200908089A ZA200908089B ZA 200908089 B ZA200908089 B ZA 200908089B ZA 200908089 A ZA200908089 A ZA 200908089A ZA 200908089 A ZA200908089 A ZA 200908089A ZA 200908089 B ZA200908089 B ZA 200908089B
Authority
ZA
South Africa
Prior art keywords
induction
dendritic cells
mature dendritic
tolerogenic phenotype
tolerogenic
Prior art date
Application number
ZA200908089A
Other languages
English (en)
Inventor
Herrera Jose M Carballido
Vries Jan E De
Ulf Korthaeuer
Maria Grazia Roncarolo
Sylvia Adriana Gregori
Original Assignee
Novartis Ag
San Raffaele Centro Fond
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, San Raffaele Centro Fond filed Critical Novartis Ag
Publication of ZA200908089B publication Critical patent/ZA200908089B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/289—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD45
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ZA200908089A 2007-06-05 2009-11-17 Induction of tolerogenic phenotype in mature dendritic cells ZA200908089B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07109672 2007-06-05

Publications (1)

Publication Number Publication Date
ZA200908089B true ZA200908089B (en) 2010-07-28

Family

ID=39721982

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200908089A ZA200908089B (en) 2007-06-05 2009-11-17 Induction of tolerogenic phenotype in mature dendritic cells

Country Status (17)

Country Link
US (1) US20100183602A1 (xx)
EP (1) EP2160410A1 (xx)
JP (1) JP2010529078A (xx)
KR (1) KR20100035643A (xx)
CN (1) CN101687928A (xx)
AU (1) AU2008258646A1 (xx)
BR (1) BRPI0812205A2 (xx)
CA (1) CA2689570A1 (xx)
CL (1) CL2008001620A1 (xx)
EA (1) EA200901621A1 (xx)
IL (1) IL202230A0 (xx)
MA (1) MA31667B1 (xx)
MX (1) MX2009013220A (xx)
TN (1) TN2009000494A1 (xx)
TW (1) TW200907061A (xx)
WO (1) WO2008148761A1 (xx)
ZA (1) ZA200908089B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8067237B2 (en) 2005-12-13 2011-11-29 President And Fellows Of Harvard College Scaffolds for cell transplantation
US9770535B2 (en) 2007-06-21 2017-09-26 President And Fellows Of Harvard College Scaffolds for cell collection or elimination
US9370558B2 (en) 2008-02-13 2016-06-21 President And Fellows Of Harvard College Controlled delivery of TLR agonists in structural polymeric devices
WO2009102465A2 (en) 2008-02-13 2009-08-20 President And Fellows Of Harvard College Continuous cell programming devices
CA2768552A1 (en) * 2009-07-31 2011-02-03 President And Fellows Of Harvard College Programming of cells for tolerogenic therapies
EP2305277A1 (en) * 2009-09-18 2011-04-06 Forskarpatent I Syd AB Use of tolerogenic dendritic cells in treatment and prevention of atherosclerosis
AU2011311904B2 (en) 2010-10-06 2016-02-25 President And Fellows Of Harvard College Injectable, pore-forming hydrogels for materials-based cell therapies
ES2878089T3 (es) 2011-04-28 2021-11-18 Harvard College Armazones tridimensionales macroscópicos preformados inyectables para administración mínimamente invasiva
US9675561B2 (en) 2011-04-28 2017-06-13 President And Fellows Of Harvard College Injectable cryogel vaccine devices and methods of use thereof
WO2012149393A2 (en) 2011-04-29 2012-11-01 Selecta Biosciences, Inc. Tolerogenic synthetic nanocarriers for antigen-specific deletion of t effector cells
EP2714073B1 (en) 2011-06-03 2021-03-10 President and Fellows of Harvard College In situ antigen-generating cancer vaccine
WO2013036296A1 (en) * 2011-09-06 2013-03-14 Selecta Biosciences, Inc. Compositions and methods for producing antigen-specific induced tolerogenic dendritic cells with synthetic nanocarriers
DK2838515T3 (da) 2012-04-16 2020-02-24 Harvard College Mesoporøse siliciumdioxidsammensætninger til modulering af immunresponser
KR20240119156A (ko) 2013-05-03 2024-08-06 셀렉타 바이오사이언시즈, 인크. 제i형 및 제iv형 과민성을 감소시키기 위한 관용유발 합성 나노담체의 국부, 병용 투여
US10682400B2 (en) 2014-04-30 2020-06-16 President And Fellows Of Harvard College Combination vaccine devices and methods of killing cancer cells
AU2015311708A1 (en) 2014-09-07 2017-02-02 Selecta Biosciences, Inc. Methods and compositions for attenuating exon skipping anti-viral transfer vector immune responses
EP3250250A4 (en) 2015-01-30 2019-05-22 President and Fellows of Harvard College PERITUMORAL AND INTRATUMORAL MATERIALS FOR CANCER THERAPY
JP7094533B2 (ja) 2015-04-10 2022-07-04 プレジデント アンド フェローズ オブ ハーバード カレッジ 免疫細胞捕捉デバイスおよびその製造および使用方法
CN115531609A (zh) 2016-02-06 2022-12-30 哈佛学院校长同事会 重塑造血巢以重建免疫
EP3484448A4 (en) 2016-07-13 2020-04-01 President and Fellows of Harvard College MIMETIC SCAFFOLDS OF CELLS HAVING ANTIGEN AND METHODS OF PREPARING AND USING THEM
EP3592389A1 (en) 2017-03-11 2020-01-15 Selecta Biosciences, Inc. Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant
JP2021524282A (ja) * 2018-05-17 2021-09-13 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー ホスファターゼ動員による受容体の阻害

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0103389D0 (en) * 2001-02-12 2001-03-28 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
BRPI0812205A2 (pt) 2014-11-25
TW200907061A (en) 2009-02-16
US20100183602A1 (en) 2010-07-22
CA2689570A1 (en) 2008-12-11
AU2008258646A1 (en) 2008-12-11
JP2010529078A (ja) 2010-08-26
WO2008148761A1 (en) 2008-12-11
TN2009000494A1 (en) 2011-03-31
MA31667B1 (fr) 2010-09-01
MX2009013220A (es) 2010-04-09
KR20100035643A (ko) 2010-04-05
IL202230A0 (en) 2010-06-16
CL2008001620A1 (es) 2009-02-20
EA200901621A1 (ru) 2010-06-30
EP2160410A1 (en) 2010-03-10
CN101687928A (zh) 2010-03-31

Similar Documents

Publication Publication Date Title
ZA200908089B (en) Induction of tolerogenic phenotype in mature dendritic cells
IL276146A (en) Laboratory methods for increasing the vitality of the cells of the immune system
IL217552A0 (en) Methods and compositions for in vitro and in vivo chondrogenesis
IL216128A (en) Antibodies to ngf with increased in vivo stability
HK1165962A1 (en) Sustained release of nutrients in vivo
EP2391711A4 (en) NEW CELL LINES AND METHOD
EP2335339A4 (en) battery charger
AU326555S (en) Battery charger
HK1131266A1 (en) Charger and charging method thereof
GB0900097D0 (en) Improvements in hybrid riser towers and fabrication thereof
EP2222344A4 (en) DENDRITIC CELL VACCINE COMPOSITIONS AND USES THEREOF
EP2425018A4 (en) IN VIVO CONSTRUCTION OF DNA BY HOMOLOGOUS RECOMBINATION
EP2305164A4 (en) DENTAL LOAD DISPENSER
EP2227540A4 (en) DIFFERENTIATION OF HUMAN CELLS
EP2497769A4 (en) PYRROLOCHINOLINCHINONE IN FREE FORM
IL208579A0 (en) Methods and use of inducing a poptosis in cancer cells
EP2362535A4 (en) BATTERY CHARGER
GB2445978B (en) Improvements in battery chargers
GB0802154D0 (en) Improvements in electrical means
GB0912437D0 (en) Improvements in and relating to chair lifts
PL2307448T3 (pl) Wytwarzanie polilizyny i poliornityny o małym ciężarze cząsteczkowym z wysoką wydajnością
EP2113029A4 (en) IN VIVO GENERAL MUTAGENESIS
GB2450466B (en) Improvements in and relating to electric plugs
GB0725303D0 (en) Improvement in the structure of an electrical receptacle
GB0904880D0 (en) Gravity power renewed